DEPARTMENT OF HEALTH
(Board of Pharmacy)
[Filed June 30, 1997, 11:16 a.m.]
The Following Sections are Proposed for Expedited Repeal: Chapter 247-897 WAC, Drug availability; amygdalin WAC 246-897-030, 246-897-040, and 246-897-050; dimethyl sulfoxide, WAC 246-897-120, 246-897-130, 246-897-140, 246-897-150, 246-897-160, 246-897-170, 246-897-180, and 246-897-190.
Rules Proposed for Expedited Repeal Meet the Following Criteria: Other rules of the agency or of another agency govern the same activity as the rule, making the rule redundant.
Any person who objects to the repeal of the rule must file a written objection to the repeal within thirty days after publication of this preproposal statement of inquiry.
Address Your Objection to: Lisa Salmi, Washington State Board of Pharmacy, P.O. Box 47863, Olympia, WA 98504-7863, FAX (360) 586-4359.
Reason the Expedited Repeal of the Rule is Appropriate: Licensing, manufacturing and labeling requirements are covered under chapter 246-895 WAC making rules redundant.
June 4, 1997
Acting Executive Director